Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India
· Delayed Price · Currency is INR 86.30
-4.50 (-4.96%)
At close: Mar 4, 2026
NSE:ARISTO Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Revenue | 3,604 | 3,181 | 2,451 | 2,179 | 1,658 | 1,672 | Upgrade
|
| Revenue Growth (YoY) | 10.39% | 29.75% | 12.53% | 31.43% | -0.87% | -16.90% | Upgrade
|
| Cost of Revenue | 3,381 | 2,958 | 2,265 | 1,960 | 1,472 | 1,502 | Upgrade
|
| Gross Profit | 222.63 | 222.43 | 186.49 | 218.55 | 185.63 | 170.66 | Upgrade
|
| Selling, General & Admin | 43.81 | 41.4 | 37.28 | 58.42 | 53.94 | 36.3 | Upgrade
|
| Other Operating Expenses | 86.46 | 86.19 | 63.56 | 72.19 | 79.36 | 90.91 | Upgrade
|
| Operating Expenses | 158.1 | 153.62 | 116.55 | 145.97 | 144.29 | 134.71 | Upgrade
|
| Operating Income | 64.54 | 68.82 | 69.94 | 72.58 | 41.34 | 35.95 | Upgrade
|
| Interest Expense | -17.66 | -18.09 | -16.68 | -22.07 | -18.82 | -22.09 | Upgrade
|
| Interest & Investment Income | 0.57 | 0.57 | 0.46 | 0.56 | 0.24 | 0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.4 | 2.4 | 0.8 | -2.42 | -0.1 | 2.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.1 | 0.29 | -0.45 | -1.26 | -2.42 | -1.05 | Upgrade
|
| EBT Excluding Unusual Items | 48.74 | 53.98 | 54.08 | 47.39 | 20.25 | 14.98 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.69 | 0.69 | -0 | - | 0.16 | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.6 | - | Upgrade
|
| Pretax Income | 49.43 | 54.67 | 54.08 | 47.39 | 19.8 | 14.98 | Upgrade
|
| Income Tax Expense | 12.64 | 14.04 | 15.12 | 11.77 | 5.47 | 4.22 | Upgrade
|
| Net Income | 36.79 | 40.63 | 38.96 | 35.62 | 14.34 | 10.76 | Upgrade
|
| Net Income to Common | 36.79 | 40.63 | 38.96 | 35.62 | 14.34 | 10.76 | Upgrade
|
| Net Income Growth | -37.38% | 4.30% | 9.36% | 148.44% | 33.29% | 6.78% | Upgrade
|
| Shares Outstanding (Basic) | 7 | 7 | 7 | 5 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 7 | 7 | 5 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | 0.06% | - | 28.43% | 6.13% | - | - | Upgrade
|
| EPS (Basic) | 5.40 | 5.97 | 5.72 | 6.72 | 2.87 | 2.15 | Upgrade
|
| EPS (Diluted) | 5.40 | 5.97 | 5.72 | 6.72 | 2.87 | 2.15 | Upgrade
|
| EPS Growth | -37.40% | 4.34% | -14.88% | 134.14% | 33.27% | 6.78% | Upgrade
|
| Free Cash Flow | 44.12 | 49.1 | 10.45 | -68.44 | 35.29 | 2.95 | Upgrade
|
| Free Cash Flow Per Share | 6.48 | 7.21 | 1.54 | -12.91 | 7.07 | 0.59 | Upgrade
|
| Dividend Per Share | - | 0.500 | 0.400 | 0.250 | - | - | Upgrade
|
| Dividend Growth | - | 25.00% | 60.00% | - | - | - | Upgrade
|
| Gross Margin | 6.18% | 6.99% | 7.61% | 10.03% | 11.20% | 10.21% | Upgrade
|
| Operating Margin | 1.79% | 2.16% | 2.85% | 3.33% | 2.49% | 2.15% | Upgrade
|
| Profit Margin | 1.02% | 1.28% | 1.59% | 1.64% | 0.86% | 0.64% | Upgrade
|
| Free Cash Flow Margin | 1.22% | 1.54% | 0.43% | -3.14% | 2.13% | 0.18% | Upgrade
|
| EBITDA | 92.37 | 94.84 | 85.65 | 87.95 | 52.33 | 43.44 | Upgrade
|
| EBITDA Margin | 2.56% | 2.98% | 3.49% | 4.04% | 3.16% | 2.60% | Upgrade
|
| D&A For EBITDA | 27.83 | 26.02 | 15.71 | 15.36 | 10.99 | 7.49 | Upgrade
|
| EBIT | 64.54 | 68.82 | 69.94 | 72.58 | 41.34 | 35.95 | Upgrade
|
| EBIT Margin | 1.79% | 2.16% | 2.85% | 3.33% | 2.49% | 2.15% | Upgrade
|
| Effective Tax Rate | 25.56% | 25.68% | 27.96% | 24.83% | 27.60% | 28.20% | Upgrade
|
| Revenue as Reported | 3,607 | 3,185 | 2,453 | 2,182 | 1,660 | 1,672 | Upgrade
|
| Advertising Expenses | - | 0.14 | 0.3 | 0.25 | 0.04 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.